Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curtis Mathes Therapeutics was a healthcare technology subsidiary of Curtis Mathes Corporation focused on therapeutic lighting and red light therapy devices. The company described its business as the research, development, manufacturing, and sale of solid-state lighting products for phototherapy applications, including recovery from burns, lacerations, deep muscle tissue damage, inflammation, and neuropathic conditions. Public materials indicate it was developing red light therapy systems based on photobiomodulation and near-infrared light concepts, with early anecdotal human-use observations rather than a conventional drug-development pipeline. The entity appears to have operated as a small private subsidiary rather than a standalone public biotech company. Corporate registry information indicates the Texas entity is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curtis Mathes Therapeutics.